This was evidenced by a CCL2-promoted formation of primary and secondary tumor spheroids that contained more self-renewing CSCs (82), and by the fact that stimulation of breast tumor cells with CCL5 increased the CD44+/CD24− sub-population (47). The gene discussed is CD44; the disease is neoplasm.